Stage IV Childhood Large Cell Lymphoma Completed Phase 2 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0030017 (Stage IV Childhood Large Cell Lymphoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs